| Literature DB >> 25965188 |
Ji-Yeong Kim1, Jae-Hun Yang1, Ji-Hee Lee1, Goeun Choi1, Dae-Hwan Park1, Mi-Rea Jo2, Soo-Jin Choi2, Jin-Ho Choy3.
Abstract
Artesunic acid (ASH), an antimalarial drug, has low oral bioavailability due to its low aqueous solubility. To overcome this problem, artesunate (AS) was intercalated into zinc basic salt (ZBS) via co-precipitation. AS was immobilized with a tilted double layer arrangement, which was also confirmed by XRD and 1-D electron density mapping. In order to decrease the release rate of AS under gastrointestinal conditions and to simultaneously increase the release rate of AS under intestinal conditions, ZBS-AS was coated with EUDRAGIT L100 (ZBS-AS-L100). Finally, we performed an in-vivo pharmacokinetic study to compare the oral bioavailability of AS of ZBS-AS-L100 with that of ASH. Surprisingly, it was found that the former is 5.5 times greater than the latter due to an enhanced solubility of AS thanks to the ternary hybridization with ZBS and EUDRAGIT L100. Therefore, the present ZBS-AS-L100 system has a great potential as a novel antimalarial drug formulation with pH selectivity and enhanced bioavailability.Entities:
Keywords: artesunic acid; bioavailability; layered compounds; polymers; zinc basic salt
Mesh:
Substances:
Year: 2015 PMID: 25965188 DOI: 10.1002/asia.201500347
Source DB: PubMed Journal: Chem Asian J ISSN: 1861-471X